Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20517
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLoader, Jordan-
dc.contributor.authorKhouri, Charles-
dc.contributor.authorTaylor, Frances-
dc.contributor.authorStewart, Simon-
dc.contributor.authorLorenzen, Christian-
dc.contributor.authorCracowski, Jean-Luc-
dc.contributor.authorWalther, Guillaume-
dc.contributor.authorRoustit, Matthieu-
dc.date2019-03-18-
dc.date.accessioned2019-04-02T01:07:34Z-
dc.date.available2019-04-02T01:07:34Z-
dc.date.issued2019-06-
dc.identifier.citationObesity reviews 2019; 20(6): 906-920-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/20517-
dc.description.abstractThis study aimed to assess, for the first time, the change in vascular reactivity across the full spectrum of cardiometabolic health. Systematic searches were conducted in MEDLINE and EMBASE databases from their inception to March 13, 2017, including studies that assessed basal vascular reactivity in two or more of the following health groups (aged ≥18 years old): healthy, overweight, obesity, impaired glucose tolerance, metabolic syndrome, or type 2 diabetes with or without complications. Direct and indirect comparisons of vascular reactivity were combined using a network meta-analysis. Comparing data from 193 articles (7226 healthy subjects and 19344 patients), the network meta-analyses revealed a progressive impairment in vascular reactivity (flow-mediated dilation data) from the clinical onset of an overweight status (-0.41%, 95% CI, -0.98 to 0.15) through to the development of vascular complications in those with type 2 diabetes (-4.26%, 95% CI, -4.97 to -3.54). Meta-regressions revealed that for every 1 mmol/l increase in fasting blood glucose concentration, flow-mediated dilation decreased by 0.52%. Acknowledging that the time course of disease may vary between patients, this study demonstrates multiple continuums of vascular dysfunction where the severity of impairment in vascular reactivity progressively increases throughout the pathogenesis of obesity and/or insulin resistance, providing information that is important to enhancing the timing and effectiveness of strategies that aim to improve cardiovascular outcomes.-
dc.language.isoeng-
dc.subjectendothelial dysfunction-
dc.subjectinsulin resistance-
dc.subjectobesity-
dc.subjectvascular function-
dc.titleThe continuums of impairment in vascular reactivity across the spectrum of cardiometabolic health: A systematic review and network meta-analysis.-
dc.typeJournal Article-
dc.identifier.journaltitleObesity reviews-
dc.identifier.affiliationHatter Institute for Reducing Cardiovascular Disease in Africa, The University of Cape Town, Cape Town, South Africa-
dc.identifier.affiliationInserm U1042, Université Grenoble Alpes, Grenoble, Franceen
dc.identifier.affiliationClinical Pharmacology, Grenoble Alpes University Hospital, Grenoble, Franceen
dc.identifier.affiliationLAPEC EA4278, Avignon Université, Avignon, Franceen
dc.identifier.affiliationSchool of Exercise Science, Australian Catholic University, Melbourne, Australiaen
dc.identifier.affiliationMary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationLAPEC EA4278, Avignon Université, Avignon, Franceen
dc.identifier.doi10.1111/obr.12831-
dc.identifier.orcid0000-0001-5623-7478-
dc.identifier.pubmedid30887713-
dc.type.austinJournal Article-
dc.type.austinReview-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

2
checked on Feb 1, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.